Page last updated: 2024-11-01

nifedipine and Psoriasis

nifedipine has been researched along with Psoriasis in 4 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"Thirteen psoriatic patients with hypertension during the course of cyclosporin A therapy were treated for 25 months with a calcium channel blocker, sustained-release nifedipine, to study the clinical antihypertensive effects and adverse events during treatment with both drugs."9.08Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis. ( Furue, M; Koga, T; Nakayama, J, 1998)
"Thirteen psoriatic patients with hypertension during the course of cyclosporin A therapy were treated for 25 months with a calcium channel blocker, sustained-release nifedipine, to study the clinical antihypertensive effects and adverse events during treatment with both drugs."5.08Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis. ( Furue, M; Koga, T; Nakayama, J, 1998)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edwards, BD1
Chalmers, RJ1
O'Driscoll, J1
Lawson, RS1
Testa, HJ1
Ballardie, FW1
Domínguez Ortega, L1
López Estebaranz, JL1
de Argila, D1
Nakayama, J1
Koga, T1
Furue, M1

Trials

1 trial available for nifedipine and Psoriasis

ArticleYear
Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
    European journal of dermatology : EJD, 1998, Volume: 8, Issue:8

    Topics: Adult; Aged; Blood Pressure Determination; Calcium Channel Blockers; Cyclosporine; Delayed-Action Pr

1998

Other Studies

3 other studies available for nifedipine and Psoriasis

ArticleYear
Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, Volume: 8, Issue:10

    Topics: Adolescent; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Cyclosporine; Drug Therapy, Comb

1993
[Effectiveness of calcium antagonists in the treatment of psoriasis].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:10

    Topics: Calcium Channel Blockers; Humans; Male; Middle Aged; Nifedipine; Psoriasis

1995
[Psoriasis and nifedipine].
    Revista clinica espanola, 1997, Volume: 197, Issue:12

    Topics: Administration, Oral; Calcium Channel Blockers; Female; Humans; Middle Aged; Nifedipine; Psoriasis

1997